Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
To assess genetic features and intraocular cytokine profiles of non-responders to anti-VEGF
treatment of exudative age-related macular degeneration. Also to assess necessity and
frequency of pro re nate medical re-treatment.